STERIS plc (STE) director logs option exercise, share sale and new awards

Q: What options did STERIS (STE) director Mohsen Sohi exercise in this Form 4?

Mohsen Sohi exercised 4,058 Director Stock Options on 2026-08-12 at an exercise price of $86.23 per share. The options were fully vested and originated from a prior redomiciliation-related grant, subject to the same terms as the original option.

Q: How many STERIS (STE) shares did Mohsen Sohi sell and at what price?

On 2026-08-12, Mohsen Sohi sold 4,058 Ordinary Shares at a weighted average price of $235.78 per share. Individual sale prices ranged from $235.73 to $235.89 , and detailed trade-level pricing is available upon request to the issuer or SEC staff.

Q: What new stock options did STERIS (STE) grant to Mohsen Sohi?

On 2026-08-10, Mohsen Sohi received 1,099 nonqualified stock options to buy STERIS ordinary shares at an exercise price of $238.91 per share. These options are fully vested and exercisable immediately, with an expiration date of 2036-08-10 .

Q: What are the Career Restricted Stock Units reported for STERIS (STE) director Mohsen Sohi?

Mohsen Sohi was granted 1,229 Career Restricted Stock Units on 2026-08-10, each representing one STERIS ordinary share. The RSUs are fully vested immediately and will be settled in shares six months after his Board service ends.

Q: Were the STERIS (STE) equity awards to Mohsen Sohi fully vested at grant?

Yes. The 1,099 nonqualified stock options granted on 2026-08-10 are fully vested and immediately exercisable, and the 1,229 Career Restricted Stock Units granted the same day are also fully vested, with settlement deferred until six months after Board service cessation.

Q: Does this STERIS (STE) Form 4 indicate planned trades under Rule 10b5-1?

The filing’s Rule 10b5-1 plan checkbox is not marked as affirmative , and the footnotes do not reference any trading plan. The reported sale and exercises are therefore not described in the document as occurring under a Rule 10b5-1 plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

STERIS plc director Mohsen Sohi reported several equity transactions. On 2026-08-12, he exercised 4,058 options with a $86.23 exercise price into ordinary shares and sold 4,058 shares at a weighted average price of $235.78 per share, with individual sale prices ranging from $235.73 to $235.89. On 2026-08-10, he received a grant of 1,099 fully vested nonqualified stock options with a $238.91 exercise price and 1,229 fully vested Career Restricted Stock Units, each RSU representing one ordinary share to be delivered six months after his Board service ends.

Insider Trade Summary

Exercise and Sale: 4,058 shares ($607K approx. pre-tax spread)

Exercise and Sale 5 txns

Insider Sohi Mohsen

Role Director

Sold 4,058 shs ($957K)

Approx. gross sale proceeds $957K

Approx. exercise cost $350K

Approx. pre-tax spread $607K

Type	Security	Shares	Price	Value
Exercise	Director Stock Option (right to buy) ^F5	4,058	$0.00	$0.00
Exercise	Ordinary Shares	4,058	$86.23	$350K
Sale	Ordinary Shares ^F1	4,058	$235.78	$957K
Grant/Award	Director Stock Option (right to buy) ^F2	1,099	$0.00	$0.00
Grant/Award	Career Restricted Stock Units ^{F3, F4}	1,229	$0.00	$0.00

Holdings After Transaction: Director Stock Option (right to buy) — 1,099 shares (Direct); Career Restricted Stock Units — 8,979 shares (Direct); Ordinary Shares — 24,305 shares (Direct)

Footnotes (5)

F1. Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2. These nonqualified stock options are fully vested and are exercisable immediately.
F3. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F4. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
F5. This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

Key Figures

Options exercised: 4,058 shares Exercise price: $86.23 per share Shares sold: 4,058 shares +5 more

8 metrics

Options exercised 4,058 shares Director Stock Options exercised into Ordinary Shares on 2026-08-12 at $86.23 per share

Exercise price $86.23 per share Exercise price of 4,058 Director Stock Options exercised on 2026-08-12

Shares sold 4,058 shares Ordinary Shares sold on 2026-08-12 following option exercise

Weighted average sale price $235.78 per share Weighted average price for sales ranging from $235.73 to $235.89 on 2026-08-12

New option grant 1,099 options Nonqualified stock options granted on 2026-08-10 with a $238.91 exercise price

New option exercise price $238.91 per share Exercise price for 1,099 nonqualified stock options granted 2026-08-10

Career RSUs granted 1,229 units Career Restricted Stock Units granted on 2026-08-10, each for one ordinary share

RSU holding after grant 8,979 units Total Career Restricted Stock Units held directly after 1,229-unit grant

Key Terms

nonqualified stock options, Career Restricted Stock Units, weighted average sale price, redomiciliation

4 terms

nonqualified stock options financial

"These nonqualified stock options are fully vested and are exercisable immediately."

A nonqualified stock option is a company-issued right that lets an employee or contractor buy shares later at a preset price, like a coupon to purchase stock regardless of the market price. It matters to investors because when the option is used the recipient owes ordinary-income tax on the difference between market and preset price, which affects the holder’s financial decisions and can change the company’s share count and reported expenses.

Career Restricted Stock Units financial

"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"

weighted average sale price financial

"Price reflects a weighted average sale price for multiple transactions ranging"

redomiciliation regulatory

"received in connection with the redomiciliation of STERIS plc to Ireland in March 2019"

Redomiciliation is when a company legally changes its country of incorporation while keeping the same business and assets, like moving a house to a new neighborhood but keeping the same furniture. Investors care because the company then follows a different set of laws and tax rules, which can change shareholder rights, reporting standards, dividend treatment and the ease of trading the stock, potentially affecting risk and return.

FAQ

What options did STERIS (STE) director Mohsen Sohi exercise in this Form 4?

Mohsen Sohi exercised 4,058 Director Stock Options on 2026-08-12 at an exercise price of $86.23 per share. The options were fully vested and originated from a prior redomiciliation-related grant, subject to the same terms as the original option.

How many STERIS (STE) shares did Mohsen Sohi sell and at what price?

On 2026-08-12, Mohsen Sohi sold 4,058 Ordinary Shares at a weighted average price of $235.78 per share. Individual sale prices ranged from $235.73 to $235.89, and detailed trade-level pricing is available upon request to the issuer or SEC staff.

What new stock options did STERIS (STE) grant to Mohsen Sohi?

On 2026-08-10, Mohsen Sohi received 1,099 nonqualified stock options to buy STERIS ordinary shares at an exercise price of $238.91 per share. These options are fully vested and exercisable immediately, with an expiration date of 2036-08-10.

What are the Career Restricted Stock Units reported for STERIS (STE) director Mohsen Sohi?

Mohsen Sohi was granted 1,229 Career Restricted Stock Units on 2026-08-10, each representing one STERIS ordinary share. The RSUs are fully vested immediately and will be settled in shares six months after his Board service ends.

Were the STERIS (STE) equity awards to Mohsen Sohi fully vested at grant?

Yes. The 1,099 nonqualified stock options granted on 2026-08-10 are fully vested and immediately exercisable, and the 1,229 Career Restricted Stock Units granted the same day are also fully vested, with settlement deferred until six months after Board service cessation.

Does this STERIS (STE) Form 4 indicate planned trades under Rule 10b5-1?

The filing’s Rule 10b5-1 plan checkbox is not marked as affirmative, and the footnotes do not reference any trading plan. The reported sale and exercises are therefore not described in the document as occurring under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 04:34 PM Accepted by SEC EDGAR 08/12/2026 - 04:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sohi Mohsen

(Last)

(First)

(Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2

D02 R296

(City)

(State)

(Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/12/2026		M		4,058	A	$86.23	28,363	D
Ordinary Shares	08/12/2026		S		4,058	D	$235.78⁽¹⁾	24,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Director Stock Option (right to buy)	$238.91	08/10/2026		A		1,099		⁽²⁾	08/10/2036	Ordinary Shares	1,099	$0	1,099	D
Career Restricted Stock Units	⁽³⁾	08/10/2026		A		1,229		⁽⁴⁾	⁽⁴⁾	Ordinary Shares	1,229	$0	8,979	D
Director Stock Option (right to buy)	$86.23	08/12/2026		M			4,058	⁽⁵⁾	08/09/2027	Ordinary Shares	4,058	$0	0	D

Explanation of Responses:

1. Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

2. These nonqualified stock options are fully vested and are exercisable immediately.

3. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

4. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

5. This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR